In an unprecedented era of vaccine propaganda, medical misinformation, false-positive nasal swab PCR tests, problematic spike protein vaccines that don’t halt infection or transmission, and questionable preventive measures (face masks, social distancing), scientific scrutiny has yet to fully explain why even a laboratory made gain-of-function virus strikes so hard against elderly adults.
Most of the deaths attributed to Covid-19 coronavirus infection occur among very old, infirm, fragile, morbid subjects. But why this coronavirus over other viruses? Maybe there is an overlooked answer to that question.
The ubiquitous but overlooked virus
A largely unmentioned virus that is innocuous (usually symptomless and dormant) but ubiquitous (present but dormant in most people), which represents co-infection, appears to be what has caused most of the hospitalizations and deaths reported for aged adults with COVID-19 coronavirus infection.
This virus ends up infecting cells that look overly large (mega-sized). It is called cyto (cell) megalo (overly large) virus or cytomegalovirus (CMV). It is unique to humans, not animals.
NO vaccine and guess who is making one?
There is no approved vaccine for this virus. And guess which vaccine maker is in Stage 3 Clinical Trials for possibly the first vaccine against this often-quiescent virus that causes birth defects if it erupts in birthing mothers and induces death among older or immune-compromised adults?
The same criminal company that makes a toxic, Nuremberg Code-violating, worse-than-the-coronavirus RNA spike-protein vaccine! Yep, it’s them, again. The experimental vaccine is comprised of six RNAs that target two proteins on the surface of cytomegalovirus.
And will this vaccine maker be operating under the same contrived emergency declaration that was called for COVID-19, that waived informed consent requirements and resulted in Americans having a vaccine forced upon them? Will this vaccine be forced on human populations it lives in a dormant form most of people’s lives? God only knows once politicians get a hold of it.
Most people will be exposed to cytomegalovirus (CMV) over their lifetime.
Dormant cytomegalovirus is carried by 70-90% of the adult population and is reactivated by inflammation. One third of patients in hospital intensive care units reactivate CMV which doubles their mortality rate!
An aging factor called cell senescence results in weakened white blood cells (neutrophils, natural killer cells, macrophages). CMV infection hastens senescence of immune cells. CMV is said to accelerate the aging of naïve T-cells by 20 years.
There is agreement that Covid-19 co-infection with cytomegalovirus is associated with higher rates of mortality in older people who have an aged (senescent) immune system.
So-called naïve T-cells (T-cells that are not yet programmed to generate memory immunity), produced in abundance in the thymus gland when young, are reduced by 99% in numbers in adults over age 70. The combined senescence of T-cells plus co-infection of Covid-19 coronavirus and cytomegalovirus may be too much to overcome in aged subjects.
There is a dramatic decline in T-cells in Covid-19 patients, particularly CD8 T-cells. CMV-induced immune suppression among senior adults may increase the risk of dying from influenza or other infectious diseases as well.
CMV infection increases severity of illness
Initial CMV infection, usually in youth, produces mild or no symptoms. However, CMV co-infection is reported to increase severity and associated blood clotting among adults which have been reported with Covid-19. The difference between mild and severe Covid-19 cases may be reactivation of CMV.
CMV is not thought to cause any illness in healthy younger-aged adults unless reactivated by inflammation, such as among organ transplant patients who are given immune suppressant anti-rejection drugs.
CMV is reactivated in 30-35% of ICU COVID-19 patients which doubles their mortality rate.
Massive infiltration of white blood cells called macrophages into the lungs may carry dormant CMV that may be reactivated by Covid-19 itself.
Two life-threatening factors, overactivation of the immune system and blood clotting, are now linked to CMV.
Doctors usually don’t look for CMV infection
The diagnosis of CMV is easily missed in the ICU.
In a study of ICU Covid-19 patients co-infected with CMV, 50% showed reactivation of CMV. In another study 82% of patients experienced reactivation of CMV after admission to the ICU for Covid-19 infection.
https://www.lewrockwell.com/2021/12/no_author/what-they-are-not-telling-you-about-covid-19-hospitalizations-deaths-and-what-you-can-do-about-it/
end part 1